Follow the people · Insider
Darren Sherman
Darren Sherman files insider transactions with the SEC as a director and officer of Orchestra BioMed Holdings (OBIO). We hold 5 disclosed purchases and sales filed since 21 February 2018, 4 of them in the last 90 days.
- Files forOBIO
- Disclosed buys and sells5 in all, 4 in the last 90 days
- Last disclosure2 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 26 January 2023 — 1 September 2026Director and Officer · Orchestra BioMed Holdings (OBIO)41 Form 4 lines · source: SEC Form 4
- Filed 16 February 2018 — 10 February 2022Director · Motus GI Holdings (MOTS)26 Form 4 lines · source: SEC Form 4
Everything they disclosed
67 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 15,000 shares of Orchestra BioMed HoldingsSEC Form 42 September 2026Common Stock, par value $0.0001 per share ("Common Stock") · traded 1 September 2026 · filed 2 September 2026
- had shares withheld for tax on 4,925 shares of Orchestra BioMed HoldingsSEC Form 428 August 2026Common Stock, par value $0.0001 per share ("Common Stock") · traded 26 August 2026 · filed 28 August 2026
- ▲ bought on the open market 2,000 shares of Orchestra BioMed HoldingsSEC Form 428 August 2026Common Stock · traded 26 August 2026 · filed 28 August 2026
- ▼ sold on the open market 15,000 shares of Orchestra BioMed HoldingsSEC Form 44 August 2026Common Stock, par value $0.0001 per share · traded 3 August 2026 · filed 4 August 2026
- ▼ sold on the open market 15,000 shares of Orchestra BioMed HoldingsSEC Form 42 July 2026Common Stock, par value $0.0001 per share · traded 1 July 2026 · filed 2 July 2026
- ▼ sold on the open market 15,000 shares of Orchestra BioMed HoldingsSEC Form 42 June 2026Common Stock, par value $0.0001 per share · traded 1 June 2026 · filed 2 June 2026
- had shares withheld for tax on 4,925 shares of Orchestra BioMed HoldingsSEC Form 429 May 2026Common Stock, par value $0.0001 per share · traded 28 May 2026 · filed 29 May 2026
- had shares withheld for tax on 33,317 shares of Orchestra BioMed HoldingsSEC Form 427 March 2026Common Stock, par value $0.0001 per share · traded 25 March 2026 · filed 27 March 2026
- had shares withheld for tax on 33,317 shares of Orchestra BioMed HoldingsSEC Form 427 March 2026Common Stock, par value $0.0001 per share · traded 25 March 2026 · filed 27 March 2026
- was granted 397,000 shares of Orchestra BioMed HoldingsSEC Form 413 February 2026Common Stock, par value $0.0001 per share · traded 12 February 2026 · filed 13 February 2026
- was granted 397,000 shares of Orchestra BioMed HoldingsSEC Form 413 February 2026Common Stock, par value $0.0001 per share · traded 12 February 2026 · filed 13 February 2026
- was granted 34,974 shares of Orchestra BioMed Holdings (a derivative holding)SEC Form 46 February 2026Stock Option · traded 28 January 2026 · filed 6 February 2026
- was granted 34,974 shares of Orchestra BioMed Holdings (a derivative holding)SEC Form 46 February 2026Stock Option · traded 28 January 2026 · filed 6 February 2026
- had shares withheld for tax on 5,588 shares of Orchestra BioMed HoldingsSEC Form 42 January 2026Common Stock, par value $0.0001 per share · traded 2 January 2026 · filed 2 January 2026
- had shares withheld for tax on 5,588 shares of Orchestra BioMed HoldingsSEC Form 42 January 2026Common Stock, par value $0.0001 per share · traded 2 January 2026 · filed 2 January 2026
- had shares withheld for tax on 40,340 shares of Orchestra BioMed HoldingsSEC Form 426 November 2025Common Stock, par value $0.0001 per share · traded 25 November 2025 · filed 26 November 2025
- had shares withheld for tax on 40,340 shares of Orchestra BioMed HoldingsSEC Form 45 September 2025Common Stock, par value $0.0001 per share · traded 3 September 2025 · filed 5 September 2025
- ▲ bought on the open market 3,000 shares of Orchestra BioMed HoldingsSEC Form 425 August 2025Common Stock, par value $0.0001 per share · traded 25 August 2025 · filed 25 August 2025
- was granted 120,000 shares of Orchestra BioMed HoldingsSEC Form 48 August 2025"Common Stock, par value $0.0001 per share (""Common Stock"")" · traded 7 August 2025 · filed 8 August 2025
- had shares withheld for tax on 45,843 shares of Orchestra BioMed HoldingsSEC Form 430 May 2025"Common Stock, par value $0.0001 per share (""Common Stock"")" · traded 28 May 2025 · filed 30 May 2025
- was granted 115,708 shares of Orchestra BioMed HoldingsSEC Form 44 April 2025"Common Stock, par value $0.0001 per share (""Common Stock"")" · traded 4 April 2025 · filed 4 April 2025
- had shares withheld for tax on 31,815 shares of Orchestra BioMed HoldingsSEC Form 46 December 2024"Common Stock, par value $0.0001 per share (""Common Stock"")" · traded 5 December 2024 · filed 6 December 2024
- ▼ sold on the open market 6,804 shares of Orchestra BioMed HoldingsSEC Form 410 September 2024"Common Stock, par value $0.0001 per share (""Common Stock"")" · traded 9 September 2024 · filed 10 September 2024
- ▼ sold on the open market 6,904 shares of Orchestra BioMed HoldingsSEC Form 410 September 2024Common Stock · traded 10 September 2024 · filed 10 September 2024
- ▼ sold on the open market 6,837 shares of Orchestra BioMed HoldingsSEC Form 46 September 2024"Common Stock, par value $0.0001 per share (""Common Stock"")" · traded 4 September 2024 · filed 6 September 2024
- ▼ sold on the open market 6,961 shares of Orchestra BioMed HoldingsSEC Form 46 September 2024Common Stock · traded 5 September 2024 · filed 6 September 2024
- ▼ sold on the open market 6,819 shares of Orchestra BioMed HoldingsSEC Form 46 September 2024Common Stock · traded 6 September 2024 · filed 6 September 2024
- was granted 176,667 shares of Orchestra BioMed HoldingsSEC Form 410 May 2024"Common Stock, par value $0.0001 per share (""Common Stock"")" · traded 8 May 2024 · filed 10 May 2024
- was granted 539,667 shares of Orchestra BioMed HoldingsSEC Form 424 July 2023"Common Stock, par value $0.0001 per share (""Common Stock"")" · traded 20 July 2023 · filed 24 July 2023
- was granted 508,397 shares of Orchestra BioMed Holdings (a derivative holding)SEC Form 419 May 2023Nonstatutory Stock Option (Right to Buy) · traded 26 January 2023 · filed 19 May 2023
- was granted 116,250 shares of Orchestra BioMed Holdings (a derivative holding)SEC Form 419 May 2023Nonstatutory Stock Option (Right to Buy) · traded 26 January 2023 · filed 19 May 2023
- exercised options over 14,959 shares of Orchestra BioMed Holdings (a derivative holding)SEC Form 45 May 2023Right to Receive Earnout Shares · traded 12 April 2023 · filed 5 May 2023
- exercised options over 14,959 shares of Orchestra BioMed HoldingsSEC Form 45 May 2023"Common Stock, par value $0.0001 per share (""Common Stock"")" · traded 12 April 2023 · filed 5 May 2023
- was granted 29,918 shares of Orchestra BioMed Holdings (a derivative holding)SEC Form 45 May 2023Right to Receive Earnout Shares · traded 26 January 2023 · filed 5 May 2023
- was granted 68,819 shares of Orchestra BioMed HoldingsSEC Form 45 May 2023"Common Stock, par value $0.0001 per share (""Common Stock"")" · traded 26 January 2023 · filed 5 May 2023
- was granted 310,321 shares of Orchestra BioMed Holdings (a derivative holding)SEC Form 430 January 2023Nonstatutory Stock Option (Right to Buy) · traded 26 January 2023 · filed 30 January 2023
- was granted 46,500 shares of Orchestra BioMed Holdings (a derivative holding)SEC Form 430 January 2023Nonstatutory Stock Option (Right to Buy) · traded 26 January 2023 · filed 30 January 2023
- was granted 508,397 shares of Orchestra BioMed Holdings (a derivative holding)SEC Form 430 January 2023Nonstatutory Stock Option (Right to Buy) · traded 26 January 2023 · filed 30 January 2023
- was granted 116,250 shares of Orchestra BioMed Holdings (a derivative holding)SEC Form 430 January 2023Nonstatutory Stock Option (Right to Buy) · traded 26 January 2023 · filed 30 January 2023
- was granted 6,743 shares of Orchestra BioMed Holdings (a derivative holding)SEC Form 430 January 2023Incentive Stock Option (Right to Buy) · traded 26 January 2023 · filed 30 January 2023
- was granted 68,189 shares of Orchestra BioMed HoldingsSEC Form 430 January 2023"Common Stock, par value $0.0001 per share (""Common Stock"")" · traded 26 January 2023 · filed 30 January 2023
- was granted 50,000 shares of Motus GI Holdings (a derivative holding)SEC Form 411 February 2022Stock Option (right to buy) · traded 10 February 2022 · filed 11 February 2022
- was granted 90,521 shares of Motus GI HoldingsSEC Form 47 January 2022Common Stock, par value $0.0001 per share · traded 5 January 2022 · filed 7 January 2022
- was granted 30,000 shares of Motus GI HoldingsSEC Form 419 February 2021Common Stock, par value $0.0001 per share · traded 17 February 2021 · filed 19 February 2021
- was granted 22,191 shares of Motus GI HoldingsSEC Form 419 February 2021Common Stock, par value $0.0001 per share · traded 17 February 2021 · filed 19 February 2021
- was granted 30,000 shares of Motus GI Holdings (a derivative holding)SEC Form 419 February 2021Stock Option (right to buy) · traded 17 February 2021 · filed 19 February 2021
- was granted 9,144 shares of Motus GI HoldingsSEC Form 414 January 2021Common Stock, par value $0.0001 per share · traded 12 January 2021 · filed 14 January 2021
- ▲ bought on the open market 3,000 shares of Motus GI HoldingsSEC Form 418 December 2020Common Stock, par value $0.0001 per share · traded 17 December 2020 · filed 18 December 2020
- was granted 10,346 shares of Motus GI HoldingsSEC Form 413 October 2020Common Stock, par value $0.0001 per share · traded 12 October 2020 · filed 13 October 2020
- was granted 7,900 shares of Motus GI HoldingsSEC Form 413 July 2020Common Stock, par value $0.0001 per share · traded 10 July 2020 · filed 13 July 2020
- was granted 12,500 shares of Motus GI HoldingsSEC Form 47 February 2020Common Stock, par value $0.0001 per share · traded 6 February 2020 · filed 7 February 2020
- was granted 12,500 shares of Motus GI Holdings (a derivative holding)SEC Form 47 February 2020Stock Option (right to buy) · traded 6 February 2020 · filed 7 February 2020
- was granted 25,000 shares of Motus GI Holdings (a derivative holding)SEC Form 415 February 2019Stock Option (right to buy) · traded 13 February 2019 · filed 15 February 2019
- acquired or disposed of, other 1,000,000 shares of Motus GI HoldingsSEC Form 44 June 2018Common Stock, par value $0.0001 per share · traded 31 May 2018 · filed 4 June 2018
- acquired or disposed of, other 2,000,000 shares of Motus GI HoldingsSEC Form 44 June 2018Common Stock, par value $0.0001 per share · traded 31 May 2018 · filed 4 June 2018
- ▲ bought on the open market 1,000 shares of Motus GI HoldingsSEC Form 421 May 2018Common Stock, par value $0.0001 per share · traded 17 May 2018 · filed 21 May 2018
- converted 750 shares of Motus GI Holdings (a derivative holding)SEC Form 421 February 2018Series A Convertible Preferred Stock · traded 16 February 2018 · filed 21 February 2018
- converted 99,748 shares of Motus GI Holdings (a derivative holding)SEC Form 421 February 2018Series A Convertible Preferred Stock · traded 16 February 2018 · filed 21 February 2018
- converted 65,038 shares of Motus GI Holdings (a derivative holding)SEC Form 421 February 2018Series A Convertible Preferred Stock · traded 16 February 2018 · filed 21 February 2018
- acquired or disposed of, other 300 shares of Motus GI Holdings (a derivative holding)SEC Form 421 February 2018Warrants (right to buy) · traded 16 February 2018 · filed 21 February 2018
- acquired or disposed of, other 106,980 shares of Motus GI Holdings (a derivative holding)SEC Form 421 February 2018Warrants (right to buy) · traded 16 February 2018 · filed 21 February 2018
- acquired or disposed of, other 115,997 shares of Motus GI Holdings (a derivative holding)SEC Form 421 February 2018Warrants (right to buy) · traded 16 February 2018 · filed 21 February 2018
- ▲ bought on the open market 5,000 shares of Motus GI HoldingsSEC Form 421 February 2018Common Stock, par value $0.0001 per share · traded 16 February 2018 · filed 21 February 2018
- converted 750 shares of Motus GI HoldingsSEC Form 421 February 2018Common Stock, par value $0.0001 per share · traded 16 February 2018 · filed 21 February 2018
- ▲ bought on the open market 40,000 shares of Motus GI HoldingsSEC Form 421 February 2018Common Stock, par value $0.0001 per share · traded 16 February 2018 · filed 21 February 2018
- converted 99,748 shares of Motus GI HoldingsSEC Form 421 February 2018Common Stock, par value $0.0001 per share · traded 16 February 2018 · filed 21 February 2018
- converted 65,038 shares of Motus GI HoldingsSEC Form 421 February 2018Common Stock, par value $0.0001 per share · traded 16 February 2018 · filed 21 February 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.